lycated hemoglobin (HbA1c) is formed when glucose reacts nonenzymatically with amino acids on hemoglobin. Its concentration represents an integrated measure of glucose concentration during hemoglobin's lifespan, which is about 2-3 months (1) . Because HbA1c concentration predicts the risk for microvascular and macrovascular complications (2, 3) , it is used in the clinical setting to assess longer term glycemic control among people with diabetes mellitus. Generally, HbA1c concentrations <7% are regarded as acceptable glycemic control (4) . About 44% of US adults with diagnosed diabetes had a concentration of HbA1c <7% during 1988-1994 compared with about 36%-37.0% during 1999-2000 (5, 6). More recently, data from the National Committee for Quality Assurance showed steady increases in the percentage of patients receiving annual testing for HbA1c and decreases in the percentage of patients with poor glycemic control from 2000 to 2006 (7). Our objective was to examine trends in glycemic control among US adults with diagnosed diabetes from 1999 to 2004 using nationally representative samples.
RESEARCH DESIGN AND METHODS
The National Health and Nutrition Examination Survey (NHANES) 1999-2004 included nationally representative samples of the noninstitutionalized, civilian US population selected using a multistage, stratified sampling design (8) . Participants were asked "{Other than during pregnancy,} have you ever been told by a doctor or health professional that you have diabetes or sugar diabetes?" In addition, to answering "yes" or "no", participants could report having "borderline" diabetes. Persons with borderline diabetes were excluded from further analysis. Concentrations of glycated hemoglobin, measured as %HbA1c, were determined by using boronate affinity high-performance liquid chromatography on Primus CLC330 and Primus CLC385 instruments (Primus Corporation, Kansas City, MO). Interassay coefficients of variation were <3% (9) . All measurements were performed at the Diabetes Diagnostic Laboratory at the University of Missouri-Columbia. The method was standardized to the reference method of the Diabetes Control and Complication Trial. A plot of the mean concentrations of two levels of HbA1c controls from 1999 to 2004 shows no evidence of drift. Analyses, done by using SUDAAN to account for the complex sampling design, were limited to participants aged >=20 years who attended the mobile examination center. Prevalence ratios were estimated using log-binomial regression analysis (10) . Improvements in HbA1c were steadiest among whites but occurred primarily from 1999-2000 to 2001-2002 among African Americans and Mexican Americans. Despite these apparent differences, no significant differences in trends among the ethnic groups were found possibly due to limited statistical power. For the entire 6-year period, glycemic control was similar in men and women (p=0.235). However, white participants exhibited better control than African American (p=0.001) or Mexican American participants (p<0.001).
RESULTS

CONCLUSIONS
Although glycemic control as determined by a concentration of HbA1c <7% did not change significantly from 1988-1994 to 1999-2000 (5, 6) , it is encouraging that a significant improvement appears to have occurred from 1999-2000 to [2003] [2004] . After controlling for factors known to be associated with HbA1c (11) (12) (13) (14) , we still found a substantial increase in glycemic control suggesting that other factors must have been at work during the study period. A trend towards earlier detection of diabetes could have explained the improvement in glycemic control. However, we did not find evidence of such a trend during the study period. Therefore, it is conceivable that the concerted efforts of professional organizations and clinicians at improving glycemic control are bearing fruit. A variety of approaches can improve glycemic control (15) (16) (17) (18) (19) (20) . Learning whether these approaches or other factors may have positively impacted the recent trends in glycemic control could provide important lessons for effecting further improvements in glycemic control in the future.
Significant ethnic disparities in glycemic control were noted and are consistent with previously findings (21) . The disparity in glycemic control stands in contrast to the results from some studies that showed no or little ethnic difference in annual testing for HbA1c (22, 23) .
Some limitations should be considered. We were unable to provide separate estimates of glycemic control for type 1 and type 2 diabetes. Sample sizes were inadequate to provide detailed estimates when the sociodemographic variables were considered simultaneously.
In conclusion, our results are consistent with other data suggesting that improvements in glycemic control have occurred among patients with diabetes in the United States. As welcome as the recent favorable trends in glycemic control are, additional efforts are needed to help the approximately 40% of patients with diabetes who do not have adequate glycemic control. 
